The Molekule team will highlight the key considerations in designing primary research projects, synthesizing actionable insights from collected data, and articulating key findings into impactful and strategic presentations leading to a shared understanding.
Presented by Molekule Consulting
• An introduction to EU regulatory pathways and differences to US pathways
• How do we benchmark and make assumptions about EU regulatory timelines?
• Case studies: Examples from past EU approvals
Presented by Lifescience Dynamics
Key to this session will be addressing business needs across the lifecycle, whereby participants will:
· Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
· Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
· Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.
Presented by INOVIS
Blockbuster Competitive Intelligence is a new framework that almost nobody knows. This framework maximizes the potential of a drug and increases the impact that you can have with competitive intelligence.
So, what is it and how can you leverage it?
Blockbuster Competitive Intelligence outlines how Competitive Intelligence is used to develop, launch, and commercialize a blockbuster drug (or a drug that is critical to the success of the organization).
Over the past two decades, we have worked with multiple blockbusters and potential blockbuster products. We have experimented and innovated successful approaches while working at Roche, and Novartis. With Atacana we continue to innovate and support the majority of the top 10 pharma companies helping their blockbuster competitive intelligence strategies.
In this interactive workshop, we will share with you our Blockbuster Competitive Intelligence framework and learn from other participants what it takes to develop a winning strategy.
Our goal is to help you maximize the potential of your product and your potential for your next career move!
Presented by Atacana Group
Presented by Novartis and STADA
• Leadership
• HR Organization (hybrid working)
• New performance management approach
• New Talent management approach
Presented by Organon
It is an ongoing rollercoaster that challenges governments, nonprofits, and corporate environments. However, there is always an opportunity to thrive in uncertain times by leveraging key insights into utilizing intelligence about the future to anticipate change, understanding the various types of emergence, and avoiding disruption by imagining and building new global scenarios where humans collaborate with AI to understand emerging issues.
Presented by FFWD
We will take a fresh look at brand positioning market research and discuss how competitive simulation workshops can be used to elevate the positioning research outputs. With the help of a case study we’ll demonstrate the value of incorporating such workshops into positioning studies right at the planning stage.
Presented by Lifescience Dynamics
Presented by Menarini
Presented by Real Chemistry
However, the decision process that respondents use to determine these percentages are a black box—unknown to the marketing researchers, probably heterogeneous across respondents, and for many respondents, potentially not very accurate. In this presentation, we present the outcomes from original research conducted with prescribers to investigate the decision process and mental calculations that respondents actually use when they answer percentage allocation questions. We show the specific challenges that physicians encounter when responding to these questions and how these challenges translate into significant sources of error in the resulting data. Our presentation concludes with actionable recommendations for improving the accuracy of demand studies.
Presented by AplusA
Presented by PharmaValue Partners
Presented by Pfizer
Presented by Instar and Boehringer Ingelheim
Presented by Novartis
Presented by Alentis Therapeutics
Presented by Chiesi Farmaceutici S.p.A.
• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)
Presented by SOTIO, a.s.
Presented by STADA
Presented by Bristol Myers Squibb
While market research is squarely focused on the “customers” piece of the equation, competitive intelligence provides crucial insight into the way the market shifts as a result of competitor activity. Through this talk, we explain, with the help of some examples, when and how CI can be interwoven into market research to unlock a unique perspective of the market that is not only more comprehensive but also more forward-looking and actionable.
Presented by Lifescience Dynamics
Presented by Novartis and STADA
The traditional CI model of gathering intelligence and generating insights is not enough. Developing, launching and growing blockbuster brands require a well defined strategic decision making process.
In this presentation, we will share our proven 3 step process needed to identify your key competitors, assess several credible scenarios, determine risks and opportunities, identify the key success factors, and create an action plan to execute within your winning strategy.
The presentation incorporates learnings from leading the CI functions at Roche and Novartis, supporting the majority of Big Pharma companies CI efforts, the latest management thinking from Harvard Business School, and years of cross-functional experience within Pharma and at Atacana.
We look forward to seeing you there!
Presented by Atacana Group
Presented by FENIX and CSL Seqirus
• Information management from public domain: sifting through the ‘noise’
• Using the hybrid of technology and human touch to create successful outcomes
• Case study: ASCO2022
Presented by Larvol
Presented by Deallus
Presented by GlaxoSmithKline
Presented by Novartis
Presented by Alentis Therapeutics
• Is BI standard part of core project team or only ad hoc guest?
• How do you deliver/report your findings?
• Tips on how to get more involved (proactive vs reactive approach)
Presented by SOTIO, a.s.
Presented by Bristol Myers Squibb and Menarini
Presented by Novartis
In this talk, we will explore the use of neuromarketing techniques in the medical industry and how they can help us understand the unconscious emotions that influence medical decision making. We will present a series of case studies that reveal the emotional components driving medical decision making, and explore how this knowledge can be used to improve marketing strategies and communication in the medical industry.
Moreover, we will discuss the challenges of implementing neuromarketing techniques in the medical industry, including ethical considerations and the need for specialized training. However, the potential benefits of using these techniques to understand the unconscious emotions of patients and physicians far outweigh these challenges.
By the end of this talk, attendees will have a greater understanding of how neuromarketing techniques can be used to understand unconscious emotions in medical decision making. They will also gain insights into how to develop more effective marketing strategies and communication that appeal to the emotional and intuitive responses of both physicians and patients, ultimately leading to more successful engagement and increased sales.
Overall, this talk will provide valuable insights into the power of neuromarketing techniques to improve marketing and communication in the medical industry, and how understanding the unconscious emotions of patients and physicians is key to success in this field.
Presented by University of Amsterdam
Presented by Novartis and STADA